SUPV:NYSEGrupo Supervielle S.A. Analysis
Data as of 2026-05-27 - not real-time
$9.22
Latest Price
8/10Risk
Risk Level: High
Executive Summary
Grupo Supervielle trades at $9.22, well below its DCF‑derived upside of roughly 39% and boasts a forward P/E of 6.9 versus an industry average of 16.6, suggesting a valuation edge. However, technicals remain bearish – the 20‑day SMA (8.10) sits beneath the 50‑day (8.73) and 200‑day (9.31) averages, with price hovering near the $9.55 resistance and a solid support at $7.33. Momentum indicators are mixed: RSI at 58 signals modest strength, while MACD shows a bullish histogram despite a downtrend.
Fundamentally, the bank posted a 29% revenue surge in Q1‑26 and narrowed its net loss, with CET1 capital at a healthy 15.4%, yet operating margins remain negative and ROE is –7.8%. Debt levels are high and equity is weak, and the company pays no dividend. The Argentine operating environment adds significant regulatory, geographic and currency risk, amplified by a beta of ~2.9 and 30‑day volatility above 70%.
Fundamentally, the bank posted a 29% revenue surge in Q1‑26 and narrowed its net loss, with CET1 capital at a healthy 15.4%, yet operating margins remain negative and ROE is –7.8%. Debt levels are high and equity is weak, and the company pays no dividend. The Argentine operating environment adds significant regulatory, geographic and currency risk, amplified by a beta of ~2.9 and 30‑day volatility above 70%.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Price near resistance with bearish SMA alignment
- Bullish MACD histogram suggesting limited upside
- High volatility and beta increase short‑term risk
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- Forward P/E advantage and 39% upside potential
- Revenue growth and improving CET1 capital ratio
- Market mispricing relative to fundamentals
Long Term
> 3 yearsNeutral
Model confidence: 5/10
Key Factors
- Persistent negative earnings and weak profitability
- Elevated regulatory and macro‑economic risks in Argentina
- No dividend and high debt burden limit total return
Key Metrics & Analysis
Financial Health
Revenue Growth29.20%
Profit Margin-10.35%
P/E Ratio6.9
ROE-7.75%
ROA-1.14%
P/B Ratio5.6
Op. Cash Flow$963.8B
Industry P/E16.6
Technical Analysis
TrendBearish
RSI58.4
Support$7.33
Resistance$9.55
MA 20$8.10
MA 50$8.73
MA 200$9.31
MACDBullish
VolumeStable
Fear & Greed Index92.34
Valuation
Fair Value$255,338.13
Target Price$12.83
Upside/Downside39.16%
GradeUndervalued
TypeBlend
Risk Assessment
Beta2.90
Volatility71.27%
Sector RiskHigh
Reg. RiskHigh
Geo RiskHigh
Currency RiskHigh
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.